Agios Pharmaceuticals Inc... (AGIO)

NASDAQ: AGIO · Real-Time Price · USD

31.03

1.34 (4.51%)

At close: May 01, 2025, 3:59 PM

31.00

-0.10%

Pre-market: May 02, 2025, 08:31 AM EDT

Agios Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	76.25M	88.2M	139.26M	203.13M	127.44M	80.93M	805.42M	567.75M	573.56M
Short-Term Investments	817.46M	688.72M	643.86M	816.89M	445.49M	483.95M	514.8M	321.21M	380.56M
Long-Term Investments	638.32M	29.43M	313.87M	266.38M	97.61M	152.93M	220.12M	143.81M	32.25M
Other Long-Term Assets	4.72M	4.06M	3.96M	2.9M	1.13M	-279.04M	238K	891K	1.61M
Receivables	4.11M	2.81M	2.21M	4.38M	n/a	15.32M	10.44M	3.67M	8.31M
Inventory	27.62M	19.08M	8.49M	16.19M	14.7M	7.33M	869K	-143.81M	-32.25M
Other Current Assets	40.16M	35.02M	38.95M	n/a	33.16M	n/a	17.17M	n/a	n/a
Total Current Assets	965.6M	833.84M	832.77M	1.06B	636.68M	611.7M	613.78M	445.26M	559.89M
Property-Plant & Equipment	54.55M	69.79M	88.12M	104.23M	117.54M	126.11M	24.32M	24.43M	25.34M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	697.6M	103.28M	405.95M	373.5M	216.28M	279.04M	244.68M	169.14M	59.2M
Total Assets	1.66B	937.12M	1.24B	1.44B	852.95M	890.74M	858.46M	614.4M	619.09M
Account Payables	16.64M	9.78M	18.62M	16.7M	17.72M	21.9M	17.88M	22.77M	17.11M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	10.93M	92.52M	163.64M	190.21M
Short-Term Debt	16.78M	n/a	n/a	n/a	7.41M	6.92M	n/a	n/a	n/a
Other Current Liabilities	46.86M	23.23M	12.24M	12.15M	51.39M	27.25M	22.07M	18.64M	24.32M
Total Current Liabilities	81.16M	67.95M	62.63M	59.83M	94.39M	92.89M	93.5M	94.94M	88.43M
Long-Term Debt	n/a	n/a	n/a	n/a	97.79M	106.75M	n/a	n/a	n/a
Other Long-Term Liabilities	41.09M	1.16M	3.28M	n/a	163.48M	-106.75M	17.61M	18.16M	17.77M
Total Long-Term Liabilities	41.09M	58.14M	75.28M	85.94M	359.06M	157.33M	77.42M	143.95M	172.07M
Total Liabilities	122.24M	126.1M	137.9M	145.76M	453.45M	250.21M	170.92M	238.89M	260.5M
Total Debt	56.99M	72M	85.66M	97.09M	105.2M	113.66M	n/a	n/a	n/a
Common Stock	73K	72K	71K	71K	69K	68K	58K	49K	42K
Retained Earnings	-148.92M	-822.65M	-470.56M	-238.76M	-1.84B	-1.52B	-1.1B	-798.06M	-483.15M
Comprehensive Income	-1.52M	-441K	-12.54M	-1.2M	105K	202K	-2.17M	-1.39M	-313K
Shareholders Equity	1.54B	811.02M	1.1B	1.29B	399.5M	640.53M	687.54M	375.5M	358.59M
Total Investments	1.46B	718.16M	957.73M	1.08B	543.1M	636.88M	734.92M	465.03M	412.81M